Enanta Pharmaceuticals, Inc. (ENTA) was a big mover last session, as its shares rose over 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the uptrend for the company since Dec 16, as the stock is now up nearly 25%.
Over the last 30 days, the company witnessed two positive and one negative estimate revision. Meanwhile, the Zacks Consensus Estimate moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher lasts.
Enanta Pharmaceuticals currently carries a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
A better-ranked med-drugs stock worth considering is IGI, Laboratories, Inc. (IG) with a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment